Zolpidem Dosing for Adults
For adult patients with insomnia, take ONE 10 mg tablet at bedtime for men, or ONE 5 mg tablet at bedtime for women, with at least 7-8 hours remaining before planned awakening. 1
Sex-Specific Dosing Requirements
The FDA-mandated dosing differs by sex due to pharmacokinetic differences:
- Women: 5 mg (one 5 mg tablet)
- Men: 5 mg or 10 mg (one 5 mg or one 10 mg tablet)
Women clear zolpidem more slowly than men, resulting in higher morning blood levels and increased risk of next-day impairment at the 10 mg dose 1. This sex difference is critical—the FDA revised labeling in 2013 specifically because women experienced slower drug clearance and greater next-day driving impairment 2.
If the 5 mg dose proves ineffective in either sex, the dose may be increased to 10 mg 1. However, the 10 mg dose in women carries substantially higher risk of morning impairment affecting driving and activities requiring full alertness 1.
Special Population Adjustments
Elderly or debilitated patients: ONE 5 mg tablet only 1. These patients are especially sensitive to zolpidem's effects and face higher fall risk 1. The 5 mg dose applies regardless of sex in this population.
Hepatic impairment (mild to moderate): ONE 5 mg tablet only 1. Patients with liver disease clear zolpidem more slowly than those with normal hepatic function. Avoid zolpidem entirely in severe hepatic impairment as it may precipitate hepatic encephalopathy 1.
Critical Administration Details
- Take as a single dose immediately before bedtime—do not split the dose or readminister during the same night 1
- Ensure 7-8 hours available for sleep before needing to be alert 1
- Take on an empty stomach for maximum effectiveness 3
- Total daily dose must not exceed 10 mg 1
Evidence Base
The American Academy of Sleep Medicine 2017 guideline recommends zolpidem for both sleep onset and sleep maintenance insomnia based on trials using 10 mg doses 4. However, this predates the FDA's sex-specific dosing revisions. The guideline notes this is a WEAK recommendation, requiring clinical judgment 4.
The FDA label takes precedence here: while clinical trials used 10 mg universally, post-marketing surveillance revealed the sex-based pharmacokinetic differences necessitating lower starting doses, particularly for women 1.
Common Pitfalls to Avoid
Do not prescribe 10 mg as the starting dose for women—this is the most critical error. The 10 mg dose in women increases risk of morning impairment including dangerous driving ability 2, 1.
Do not use with alcohol or other CNS depressants without dosage adjustment, as this dramatically increases impairment risk 1.
Do not prescribe if less than 7-8 hours available for sleep, as this substantially increases next-day psychomotor impairment and driving risk 1.
Avoid in patients with severe hepatic impairment, untreated sleep apnea, or myasthenia gravis due to respiratory depression risk 1.
Duration Considerations
While the 2017 AASM guideline recommendations were based on 10 mg doses 4, evidence supports both short-term and intermittent use. Studies demonstrate efficacy with intermittent use (3-5 nights per week) for up to 8 weeks without increased pill-taking behavior or rebound insomnia 5, 6. Long-term continuous use (up to 6 months) maintains efficacy without tolerance in most patients 7, 8, though approximately 20% of users continue long-term 9.